Home>Topics>Companies>Quest Diagnostics

Quest Diagnostics DGX

  1. All
  2. Commentary
  3. Headlines
    1. Quest Diagnostics' ( DGX ) CEO Stephen Rusckowski on Q3 2014 Results - Earnings Call Transcript

      Headlines

      Thu, 23 Oct 2014

      Quest Diagnostics ' ( DGX ) CEO Stephen Rusckowski on Q3 2014 Results - Earnings Call Transcript

    2. Quest Diagnostics Incorporated ( DGX ) Q3 2014 Results - Earnings Call Webcast

      Headlines

      Thu, 23 Oct 2014

      Quest Diagnostics Incorporated ( DGX ) Q3 2014 Results - Earnings Call Webcast

    3. Quest Sees Signs of Improving Business in Third Quarter

      Commentary

      Thu, 23 Oct 2014

      Quest Diagnostics posted respectable third-quarter results ..... suggest volume and pricing are improving for Quest . We stand behind the firm's narrow ..... the moat trend is stable. We applaud Quest 's decision to walk away from unprofitable

    4. Quest operating income off 63%

      Headlines

      Thu, 23 Oct 2014

      Quest operating income off 63%

    5. Quest Diagnostics reports October 23

      Headlines

      Sun, 19 Oct 2014

      Quest Diagnostics (NYSE: DGX ) will report Q3 results on October 23 before the open. The conference call will begin at 8:30 am ET. Consensus view is EPS of $1.08 on revenues of $1.9B. Post your comment!

    6. Quest Sees Slight Volume Gain in Second Quarter, but Also Faces Price Decline

      Commentary

      Thu, 24 Jul 2014

      Quest Diagnostics released second-quarter performance ..... organic volume growth remains lackluster at Quest . On one hand, quarterly organic volume ..... quarters of declines. On the other hand, Quest continues to trail its main rival LabCorp

    7. Raising Fair Value on Sonic Healthcare to Reflect Growing Offshore Presence

      Commentary

      Wed, 11 Jun 2014

      are reimbursed under Medicare and Medicaid respectively. In the U.S., Sonic remains a minnow compared with Quest Diagnostics and LabCorp, with a market share of about 1.5% versus 15%. The U.S. market remains attractive given expected

    8. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

      Headlines

      Tue, 3 Jun 2014

      was with Oakmark Equity & Income's elimination of Quest Diagnostics DGX "> DGX . Clyde McGregor noted the following in his ..... and three that didn’t (Encana, Hospira and Quest Diagnostics )... In the case of Encana and Quest Diagnostics

    9. LabCorp's First-Quarter Volume Was Solid, but Pricing Took a Hit

      Commentary

      Mon, 28 Apr 2014

      molecular pathology codes and sequestration. As with Quest Diagnostics , we anticipate the pressure should lift somewhat now ..... believe this sets LabCorp apart from its largest rival Quest . LabCorp is on the cusp of rolling out its Beacon LBS

    10. Quest Diagnostics Posts Anemic 1Q, and Our Fair Value Estimate Is Unchanged

      Commentary

      Thu, 24 Apr 2014

      Quest Diagnostics posted tepid first-quarter performance ..... the quarter to change our thinking on Quest 's narrow economic moat. Although the ..... these slightly more positive trends, Quest 's operating margin fell yet again

    « Prev12345Next »
    Content Partners